Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • USA
Investment stages
  • Pre-Seed
  • Seed
Industries
  • AI
  • Health Tech
  • Biotechnology
About
Commodore Capital focuses on partnering with smaller biopharmaceutical firms to facilitate the development and delivery of innovative genetic and cellular therapies that translate scientific discoveries into effective clinical treatments for patients.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

Committed Capital invests in early and growth stage companies across multiple sectors, focusing on backing businesses with strong growth potential and innovative solutions.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive expertise in private equity, the fund manager has executed over 30 successful deals across various sectors, including technology and healthcare. Active in the North American market, they emphasize a data-driven investment approach, prioritizing operator-first strategies that enhance operational efficiencies. Notable exits have led to impressive returns, showcasing a commitment to both growth and value creation at the growth equity and buyout stages. Their thematic focus on disruptive innovations positions the fund favorably in rapidly evolving industries.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp